Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Liabilities and Shareholders Equity (2020 - 2025)

Stemtech's Liabilities and Shareholders Equity history spans 6 years, with the latest figure at $3.8 million for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity changed N/A year-over-year to $3.8 million; the TTM value through Sep 2025 reached $15.2 million, up 38.04%, while the annual FY2024 figure was $3.8 million, 2.69% up from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $3.8 million at Stemtech, down from $3.9 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $6.3 million in Q3 2021 and bottomed at $3.6 million in Q1 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $4.2 million (2022), against an average of $4.4 million.
  • The largest annual shift saw Liabilities and Shareholders Equity rose 14.19% in 2021 before it plummeted 30.68% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $5.7 million in 2021, then fell by 25.4% to $4.3 million in 2022, then fell by 13.68% to $3.7 million in 2023, then rose by 2.69% to $3.8 million in 2024, then decreased by 0.7% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for STEK's Liabilities and Shareholders Equity are $3.8 million (Q3 2025), $3.9 million (Q2 2025), and $3.8 million (Q1 2025).